Publisher Steve Forbes sees the potential for a bill to cut corporate taxes to pass next year.
CVS and Home Depot will be two of many retailers set to benefit in coming months from lower energy costs and a growing economy.
U.S. stock futures are lower amid weak manufacturing reports from China and the eurozone; Arizona sues GM over recalls; Best Buy to report earnings; Yahoo! scores a partnership with Mozilla.
Cramer says Agios Pharmaceuticals is unique and different and yesterday its experimental cancer drug delivered some strong results in patients with advanced leukemia.
Coverage decisions are still likely to slowly build over time but it is a clear positive that we are seeing the early adopters start to reimburse for Foundation's cancer tests.
Healthcare investors are watching closely the race between Clovis and AstraZeneca to develop competing, targeted lung cancer drugs.
U.S. stock futures are mixed; the controversial Keystone XL pipeline is rejected by U.S. Senate; Lowe's earnings top forecasts; Target to report on Wednesday.
The experimental drug from Agios, designed to attack the "metabolism" of cancer cells, has demonstrated early but strong clinical responses in a study involving patients with advanced leukemia.
Another day, another record for the S&P 500. t didn't take too much for the Dow Industrials to also hit its highest level ever. The tech-heavy Nasdaq gained the most.
There's a powerful collection of 'what's working.'
By Jeff Brown
Yes, you might need nursing-home care. But the most common figures about those needs don't tell the whole story.
U.S. stock futures slip but Tokyo shares snap back; Home Depot's earnings top forecasts; SunEdison is buying a wind power company; Senate vote is scheduled on Keystone pipeline.
Actavis is finalizing a $66 billion deal to buy Botox-maker Allergan for a combination of cash and stock.
From Keystone to pharmaceuticals, industrials and energy, the Republican wins in midterm elections create real opportunities investors can take advantage of.
Stocks are little changed in midday trading Monday after opening slightly lower on Japan slipping into recession.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV